Jane Street Group, LLC Adamas Pharmaceuticals, Inc. Transaction History

Jane Street Group, LLC

  • $384 Billion
  • Q1 2025

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 17, 2021
SELL
N/A
-22,226 Closed
0 $0
Q3 2020

Nov 17, 2020
SELL
N/A
-115,066 Reduced 83.81%
22,226 $92,000
Q2 2020

Aug 17, 2020
BUY
N/A
137,292 New
137,292 $351,000
Q1 2020

May 15, 2020
SELL
N/A
-20,918 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
N/A
-18,026 Reduced 46.29%
20,918 $79,000
Q3 2019

Nov 14, 2019
BUY
N/A
38,944 New
38,944 $199,000
Q1 2019

May 16, 2019
SELL
N/A
-42,714 Closed
0 $0
Q4 2018

Feb 15, 2019
BUY
N/A
26,527 Added 163.88%
42,714 $365,000
Q3 2018

Nov 14, 2018
BUY
N/A
16,187 New
16,187 $324,000
Q4 2017

Feb 15, 2018
SELL
N/A
-12,339 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
N/A
12,339
12,339 $261,000

About Adamas Pharmaceuticals, Inc.

ADMS Quotes by TradingView
  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email